Piramal Pharma Limited announces consolidated results for Q1FY25
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical company, today announced its standalone and consolidated results for the first quarter (Q1) ended June 30, 2024. Konsolidierte finanzielle…